Protara Therapeutics (1KPA.STU) Q3 2026 Earnings

30JulConfirmed
Q2 2026
Next
-0.31
-0.3
-0.28
-0.26

Details

Expected EPS
-0.28505512138
Actual EPS
N/A
Surprise EPS
0.29
Surprise Percent
+100%

Description

Protara Therapeutics (1KPA.STU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts